Tectonic Therapeutic | AVRO - Loan Capital


Tectonic Therapeutic reported $43K in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
Celltrion KRW 412.27B 348.97B Dec/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Gilead Sciences USD 20.86B 1.27B Mar/2026
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
MacroGenics USD 70M 256K Dec/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 60.57B 1.08B Mar/2026
Pharma Mar EUR 33.16M 3.52M Mar/2026
Qiagen NV USD 1.65B 15.23M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 13.84B 1.88B Mar/2026
Sarepta Therapeutics USD 838.16M 9.19M Mar/2026
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Takeda JPY 4.37T 99.51B Mar/2026
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026